Market leader oOh!media trades at $1.77 vs fair value $1.27. EBITDA margins 19.7%, market share 30% but facing government capture risks and competitive erosion.
View noteGovernment software leader trading at 41.6x EBITDA vs 18.5x peers. Fair value $8.71 implies -55% downside. Strong moats face Microsoft threat.
View noteStrong Sell rating with fair value $0.26 vs current $0.85. EBITDA margins of 45.7% unsustainable as gold prices normalise from record highs.
View noteNuix trades at $2.48 vs fair value $1.78. Neo platform shows 132% growth but faces 60% AI disruption probability. EBITDA margins 16.8%, churn rising to 7.1%.
View noteDevelopment-stage uranium leader with 3.10% ore grade advantage. Fair value $12.83 CAD vs current price, 82.7% projected EBITDA margins, binary regulatory catalyst November 2025.
View noteAustralia's #1 wealth platform with 89.2% ROIC trades at $37.14 vs $9.67 fair value. Exceptional margins face inevitable compression as competition intensifies.
View noteMining services contractor trading at $3.47 vs $5.96 fair value (72% upside). Strong order book visibility, conservative balance sheet, temporary OneSteel impacts clearing.
View noteMonopoly Rett syndrome treatment with 83.4% margins and A$222m cash. Fair value A$10.46 vs current A$16.93 suggests 62% overvaluation despite exceptional business quality.
View noteNick Scali trades at $19.37 vs fair value $18.34, reflecting 5.6% overvaluation. Strong ANZ market leadership with UK expansion catalyst requiring selective entry timing.
View noteHOLD rating with $3.25 fair value vs $4.49 current price. Strong trophon franchise but CORIS execution risk at 28% premium valuation.
View noteMastermyne trades at $0.14 vs $0.45 fair value following external mining disruptions. Strong safety record and technical differentiation support recovery potential.
View notePharmaceutical turnaround story trading at $0.615 vs $0.94 fair value. 54% upside potential with 31% European growth and operational recovery to 8.1% EBITDA margins.
View note